Pay in 4 interest-free payments of $5.19 Learn more
Ships within 48 hours · Estimated delivery Aug 27 - Sep 1
Retrieved 14 May 2022, from A Phase II, Randomised, Open Label Pilot Study to Evaluate the Efficacy and Safety of Two Dosage Regimens of Subcutaneous Bioresorbable Afamelanotide Implants in Patients with Mild to Moderate Acne Vulgaris
Nutrition and Metabolic Insights, 16 , 11786388231160317
and McKenna, M.C
doi: 10.3390/nu12041185 160 WangJJiHWangSLiuHZhangWZhangDet al
doi:10.1073/pnas.2014879117 Pratt E, Ma X, Liu R, et al
Performance: an R package for assessment, comparison and testing of statistical models
US$ 27.26
US$ 23.08
US$ 22.26
US$ 27.47
